Insider Selling: Liquidia (NASDAQ:LQDA) Director Sells $2,004,250.00 in Stock

Posted by on Jul 8th, 2026

Liquidia Corporation (NASDAQ:LQDA – Get Free Report) Director Stephen Bloch sold 25,000 shares of the company’s stock in a transaction dated Monday, July 6th. The stock was sold at an average price of $80.17, for a total value of $2,004,250.00. Following the sale, the director owned 830,073 shares of the company’s stock, valued at approximately $66,546,952.41. This trade represents a 2.92% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Liquidia Stock Performance

Liquidia stock traded down $1.76 during trading hours on Wednesday, reaching $79.47. 1,738,308 shares of the company were exchanged, compared to its average volume of 1,851,688. The firm has a market cap of $7.07 billion, a price-to-earnings ratio of 567.68 and a beta of 0.55. The company has a current ratio of 2.22, a quick ratio of 2.03 and a debt-to-equity ratio of 1.18. The stock has a 50-day moving average of $62.48 and a 200 day moving average of $46.03. Liquidia Corporation has a 12 month low of $12.88 and a 12 month high of $82.96.

Liquidia (NASDAQ:LQDA – Get Free Report) last released its quarterly earnings results on Monday, May 11th. The company reported $0.52 EPS for the quarter, beating analysts’ consensus estimates of $0.41 by $0.11. Liquidia had a net margin of 7.74% and a return on equity of 46.82%. The company had revenue of $132.87 million for the quarter, compared to analyst estimates of $119.44 million. The business’s quarterly revenue was up 4187.1% on a year-over-year basis. As a group, research analysts anticipate that Liquidia Corporation will post 3.02 earnings per share for the current year.

Analyst Ratings Changes

LQDA has been the subject of several recent analyst reports. Zacks Research upgraded Liquidia from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, May 5th. Oppenheimer set a $75.00 price objective on Liquidia in a research report on Friday, June 5th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Liquidia in a research note on Tuesday, April 21st. Jefferies Financial Group reissued a “buy” rating and issued a $60.00 price target on shares of Liquidia in a report on Monday, May 11th. Finally, Wells Fargo & Company boosted their price objective on shares of Liquidia from $51.00 to $62.00 and gave the stock an “overweight” rating in a report on Tuesday, May 12th. Three research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, one has issued a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $68.88.

View Our Latest Report on Liquidia

Institutional Investors Weigh In On Liquidia

Institutional investors and hedge funds have recently bought and sold shares of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Liquidia by 4.7% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 37,681 shares of the company’s stock worth $556,000 after acquiring an additional 1,700 shares during the period. Goldman Sachs Group Inc. raised its position in Liquidia by 10.7% in the first quarter. Goldman Sachs Group Inc. now owns 861,231 shares of the company’s stock worth $12,703,000 after purchasing an additional 82,955 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in Liquidia by 15.2% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 121,756 shares of the company’s stock worth $1,796,000 after purchasing an additional 16,022 shares in the last quarter. Creative Planning lifted its stake in Liquidia by 40.7% during the second quarter. Creative Planning now owns 26,840 shares of the company’s stock worth $334,000 after purchasing an additional 7,765 shares during the period. Finally, Legal & General Group Plc lifted its stake in Liquidia by 13.4% during the second quarter. Legal & General Group Plc now owns 94,152 shares of the company’s stock worth $1,174,000 after purchasing an additional 11,111 shares during the period. Institutional investors own 64.54% of the company’s stock.

About Liquidia

(Get Free Report)

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).

Featured Articles

Insider Buying and Selling by Quarter for Liquidia (NASDAQ:LQDA)

Receive News & Ratings for Liquidia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liquidia and related companies with MarketBeat.com's FREE daily email newsletter.